PTX, given it's small cap status, could easily become a takeover target by large competitors like the $3.7bn market capped loxo oncology, when it shows impressive phase 2 result. Key question is how much will big phatm offer. Will it be close to $500m like what Merck has offered Viralytic? If so, that will be a cool 25 times from current mkt cap. Let's chill out with the thought..enjoy your Halloween night
Ann: September 2018 Appendix 4C - Quarterly, page-3
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $31.40M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 3.9¢ | $72.73K | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 436541 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 560576 | 1 |
View Market Depth
| Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |